... percent of Cardio3, as of March 3. Mayo Clinic first acquired equity in Cardio3 in 2007, when it licensed stem cell research by Mayo Clinic's Dr. Andre Terzic and Dr. Atta Behfar. Its cardiopoiesis technology repairs patients' hearts by ...
http://ift.tt/1FLF4U2
http://ift.tt/1FLF4U2
No comments:
Post a Comment